He, W., Karkash, A., Kumar, P., Han, Y., Shi, J. W., Marin-Acevedo, J. A., Tran, M., Shields, M. D. (2025). Outcomes with trilaciclib versus granulocyte colony stimulating factor regarding chemotherapy-associated adverse events, dose reductions, and subsequent therapies in small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20116